APA (7th ed.) Citation

Scheijmans, F. E. V., Zomers, M. L., Fadaei, S., Onrust, M. R., van der Graaf, R., Delden, J. J. M. v., . . . van Thiel, G. J. M. W. (2022). The reimbursement for expensive medicines: Stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy. BMC Health Services Research, 22, 1. https://doi.org/10.1186/s12913-022-08690-z

Chicago Style (17th ed.) Citation

Scheijmans, Féline E. V., Margot L. Zomers, Sina Fadaei, Marthe R. Onrust, Rieke van der Graaf, Johannes J. M. van Delden, W. Ludo van der Pol, and Ghislaine J. M. W. van Thiel. "The Reimbursement for Expensive Medicines: Stakeholder Perspectives on the SMA Medicine Nusinersen and the Dutch Coverage Lock Policy." BMC Health Services Research 22 (2022): 1. https://doi.org/10.1186/s12913-022-08690-z.

MLA (9th ed.) Citation

Scheijmans, Féline E. V., et al. "The Reimbursement for Expensive Medicines: Stakeholder Perspectives on the SMA Medicine Nusinersen and the Dutch Coverage Lock Policy." BMC Health Services Research, vol. 22, 2022, p. 1, https://doi.org/10.1186/s12913-022-08690-z.